Novo Nordisk has cut its sales and profits forecasts for 2025 due to lower demand in the US for blockbuster weight loss and ...

US stock futures rose after the Trump administration announced top US officials would meet with their Chinese counterparts ...

U.S.-listed shares of Novo Nordisk are jumping in premarket trading Wednesday even as the Danish pharmaceutical giant lowered ...

Trump placed duties as high as 145% on many Chinese imports, and Beijing retaliated with import taxes of 125% on American ...

Novo Nordisk A/S surged on expectations that some competition for its blockbuster obesity shot Wegovy will subside, paving ...

Novo Nordisk on Wednesday managed the unusual feat of seeing its stock price rise after reducing its earnings outlook. But ...

COPENHAGEN (Reuters) -Obesity drugmaker Novo Nordisk said on Wednesday it would drop gender representation requirements for ...

Investing.com -- Novo Nordisk (NYSE: NVO )’s CFO, Karsten Munk Knudsen, expressed doubts on Wednesday about the potential impact of U.S. President Donald Trump’s recent executive order on the ...